Quarterly Brief (October-December 2021): A Current Expert Analysis on Important HIV Clinical Decisions
Activity Summary:
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.
This educational Quarterly Brief, covering HIV data from October through December of 2021 will discuss the most clinically relevant information including COVID-19 in PLWH, guideline updates, HIV management strategies and investigational agents.
Faculty:Paul Sax, MD and Laura Waters, MBBS, FRCP, MD
Accreditation Type:AMA, ANCC and ACPE
Launch Date:January 7, 2022
Release Date:January 7, 2022
Expiration Date: December 31, 2022
Estimated Time to Complete Activity:0.5 Hours